(ALGT) Allegiant Travel - Ratings and Ratios
Flights, Hotel, Golf, Charter, Insurance
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 51.9% |
| Value at Risk 5%th | 80.5% |
| Relative Tail Risk | -5.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.25 |
| Alpha | -19.85 |
| CAGR/Max DD | 0.13 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.402 |
| Beta | 1.885 |
| Beta Downside | 1.765 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.95% |
| Mean DD | 38.82% |
| Median DD | 43.78% |
Description: ALGT Allegiant Travel November 17, 2025
Allegiant Travel Company (NASDAQ: ALGT) is a leisure-focused carrier that targets under-served U.S. cities, operating a low-frequency, nonstop model that connects these markets to vacation destinations. The business is split between an Airline segment and a Sunseeker Resort segment, the latter encompassing a golf course and ancillary hospitality assets.
As of February 1 2025 the airline fleet comprised 119 Airbus A320-family aircraft and four Boeing 737s, enabling a cost-efficient, single-type fleet strategy. Ancillary revenue streams-such as seat-upgrade fees, baggage charges, priority boarding, and onboard food & beverage sales-supplement the relatively low base fare structure, driving an average ancillary revenue of roughly $20 per passenger in FY 2024.
Key performance indicators from the most recent filings show FY 2024 revenue of about $1.3 billion, a load factor near 85 %, and an operating margin of 7 %. The company’s exposure to discretionary consumer spending makes macro-economic drivers like consumer confidence, gasoline prices, and the health of the U.S. leisure travel market critical to its outlook.
For a deeper quantitative dive, the ValueRay platform offers a granular breakdown of ALGT’s valuation metrics and scenario analysis.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-292.9m TTM) > 0 and > 6% of Revenue (6% = 154.7m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 1.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1.05% (prev -12.18%; Δ 11.13pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 362.0m > Net Income -292.9m (YES >=105%, WARN >=100%) |
| Current Ratio 0.98 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (18.1m) change vs 12m ago 0.76% (target <= -2.0% for YES) |
| Gross Margin 29.44% (prev 14.40%; Δ 15.04pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 56.16% (prev 52.13%; Δ 4.04pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -2.24 (EBITDA TTM 2.34m / Interest Expense TTM 117.3m) >= 6 (WARN >= 3) |
Altman Z'' 0.55
| (A) -0.01 = (Total Current Assets 1.11b - Total Current Liabilities 1.14b) / Total Assets 4.39b |
| (B) 0.21 = Retained Earnings (Balance) 926.6m / Total Assets 4.39b |
| (C) -0.06 = EBIT TTM -263.1m / Avg Total Assets 4.59b |
| (D) 0.28 = Book Value of Equity 931.5m / Total Liabilities 3.38b |
| Total Rating: 0.55 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 33.35
| 1. Piotroski 3.0pt |
| 2. FCF Yield 0.34% |
| 3. FCF Margin 0.34% |
| 4. Debt/Equity 2.09 |
| 5. Debt/Ebitda 773.4 |
| 6. ROIC - WACC (= -12.83)% |
| 7. RoE -27.41% |
| 8. Rev. Trend 50.14% |
| 9. EPS Trend -35.87% |
What is the price of ALGT shares?
Over the past week, the price has changed by +3.90%, over one month by +24.31%, over three months by +32.62% and over the past year by -1.69%.
Is ALGT a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 10
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the ALGT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 69.6 | -19% |
| Analysts Target Price | 69.6 | -19% |
| ValueRay Target Price | 89.2 | 3.8% |
ALGT Fundamental Data Overview December 03, 2025
P/E Forward = 10.0908
P/S = 0.5403
P/B = 1.3699
P/EG = -14.47
Beta = 1.686
Revenue TTM = 2.58b USD
EBIT TTM = -263.1m USD
EBITDA TTM = 2.34m USD
Long Term Debt = 1.79b USD (from longTermDebt, last quarter)
Short Term Debt = 283.3m USD (from shortTermDebt, last quarter)
Debt = 2.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.81b USD (from netDebt column, last quarter)
Enterprise Value = 2.56b USD (1.39b + Debt 2.13b - CCE 956.7m)
Interest Coverage Ratio = -2.24 (Ebit TTM -263.1m / Interest Expense TTM 117.3m)
FCF Yield = 0.34% (FCF TTM 8.73m / Enterprise Value 2.56b)
FCF Margin = 0.34% (FCF TTM 8.73m / Revenue TTM 2.58b)
Net Margin = -11.36% (Net Income TTM -292.9m / Revenue TTM 2.58b)
Gross Margin = 29.44% ((Revenue TTM 2.58b - Cost of Revenue TTM 1.82b) / Revenue TTM)
Gross Margin QoQ = 16.35% (prev 17.17%)
Tobins Q-Ratio = 0.58 (Enterprise Value 2.56b / Total Assets 4.39b)
Interest Expense / Debt = 1.17% (Interest Expense 24.8m / Debt 2.13b)
Taxrate = 16.45% (-8.58m / -52.2m)
NOPAT = -219.8m (EBIT -263.1m * (1 - 16.45%)) [loss with tax shield]
Current Ratio = 0.98 (Total Current Assets 1.11b / Total Current Liabilities 1.14b)
Debt / Equity = 2.09 (Debt 2.13b / totalStockholderEquity, last quarter 1.02b)
Debt / EBITDA = 773.4 (Net Debt 1.81b / EBITDA 2.34m)
Debt / FCF = 207.2 (Net Debt 1.81b / FCF TTM 8.73m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -6.67% (Net Income -292.9m / Total Assets 4.39b)
RoE = -27.41% (Net Income TTM -292.9m / Total Stockholder Equity 1.07b)
RoCE = -9.22% (EBIT -263.1m / Capital Employed (Equity 1.07b + L.T.Debt 1.79b))
RoIC = -7.11% (negative operating profit) (NOPAT -219.8m / Invested Capital 3.09b)
WACC = 5.72% (E(1.39b)/V(3.52b) * Re(12.96%) + D(2.13b)/V(3.52b) * Rd(1.17%) * (1-Tc(0.16)))
Discount Rate = 12.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.38%
[DCF Debug] Terminal Value 51.86% ; FCFE base≈8.73m ; Y1≈5.73m ; Y5≈2.62m
Fair Price DCF = 1.55 (DCF Value 28.4m / Shares Outstanding 18.3m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -35.87 | EPS CAGR: -24.81% | SUE: -0.18 | # QB: 0
Revenue Correlation: 50.14 | Revenue CAGR: 3.34% | SUE: -1.94 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.18 | Chg30d=+0.094 | Revisions Net=+1 | Analysts=9
EPS next Year (2026-12-31): EPS=6.22 | Chg30d=+0.192 | Revisions Net=+4 | Growth EPS=+110.9% | Growth Revenue=+2.2%
Additional Sources for ALGT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle